- Home
- DNTH vs ALEX Comparison
DNTH vs ALEX Comparison
Compare DNTH & ALEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- ALEX
- Stock Information
- Founded
- DNTH 2015
- ALEX 1870
- Country
- DNTH United States
- ALEX United States
- Employees
- DNTH N/A
- ALEX N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- ALEX Real Estate Investment Trusts
- Sector
- DNTH Health Care
- ALEX Real Estate
- Exchange
- DNTH Nasdaq
- ALEX Nasdaq
- Market Cap
- DNTH 1.4B
- ALEX 1.2B
- IPO Year
- DNTH N/A
- ALEX N/A
- Fundamental
- Price
- DNTH $33.73
- ALEX $15.74
- Analyst Decision
- DNTH Strong Buy
- ALEX Buy
- Analyst Count
- DNTH 11
- ALEX 2
- Target Price
- DNTH $65.22
- ALEX $24.00
- AVG Volume (30 Days)
- DNTH 503.3K
- ALEX 431.8K
- Earning Date
- DNTH 11-05-2025
- ALEX 10-30-2025
- Dividend Yield
- DNTH N/A
- ALEX 5.75%
- EPS Growth
- DNTH N/A
- ALEX 65.09
- EPS
- DNTH N/A
- ALEX 1.01
- Revenue
- DNTH $4,854,000.00
- ALEX $226,062,000.00
- Revenue This Year
- DNTH N/A
- ALEX N/A
- Revenue Next Year
- DNTH N/A
- ALEX $2.00
- P/E Ratio
- DNTH N/A
- ALEX $15.56
- Revenue Growth
- DNTH 17.87
- ALEX N/A
- 52 Week Low
- DNTH $13.37
- ALEX $15.51
- 52 Week High
- DNTH $40.16
- ALEX $19.97
- Technical
- Relative Strength Index (RSI)
- DNTH 47.36
- ALEX 28.97
- Support Level
- DNTH $32.28
- ALEX $15.52
- Resistance Level
- DNTH $35.40
- ALEX $17.07
- Average True Range (ATR)
- DNTH 1.62
- ALEX 0.28
- MACD
- DNTH -0.20
- ALEX -0.08
- Stochastic Oscillator
- DNTH 27.78
- ALEX 14.38
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About ALEX Alexander & Baldwin Inc. REIT Holding Company
Alexander & Baldwin Inc is a Hawaii commercial real estate company. The group owns, operates, and manages million square feet of retail, industrial, and office space in Hawaii. It is a real estate investment trust (REIT) and the owner of grocery and drug-anchored retail centers in the state. It functions through two segments namely Commercial Real Estate and Land Operations. The Commercial Real Estate segment owns and manages retail, industrial spaces, and also urban ground leases in Hawaii, thereby accounting for a majority of the company's revenue. The Land Operations segment actively manages the company's land and real estate-related assets and makes optimum utilization of these assets. Geographically, the activities are carried out across the United States.